CVAC
Price
$2.59
Change
-$0.25 (-8.80%)
Updated
Apr 4 closing price
Capitalization
581.04M
16 days until earnings call
MRNA
Price
$25.11
Change
-$0.62 (-2.41%)
Updated
Apr 4 closing price
Capitalization
9.71B
24 days until earnings call
Ad is loading...

CVAC vs MRNA

Header iconCVAC vs MRNA Comparison
Open Charts CVAC vs MRNABanner chart's image
CureVac
Price$2.59
Change-$0.25 (-8.80%)
Volume$898.23K
Capitalization581.04M
Moderna
Price$25.11
Change-$0.62 (-2.41%)
Volume$16.05M
Capitalization9.71B
CVAC vs MRNA Comparison Chart
Loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVAC vs. MRNA commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVAC is a StrongBuy and MRNA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (CVAC: $2.59 vs. MRNA: $25.11)
Brand notoriety: CVAC: Not notable vs. MRNA: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVAC: 140% vs. MRNA: 142%
Market capitalization -- CVAC: $581.04M vs. MRNA: $9.71B
CVAC [@Biotechnology] is valued at $581.04M. MRNA’s [@Biotechnology] market capitalization is $9.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVAC’s FA Score shows that 0 FA rating(s) are green whileMRNA’s FA Score has 1 green FA rating(s).

  • CVAC’s FA Score: 0 green, 5 red.
  • MRNA’s FA Score: 1 green, 4 red.
According to our system of comparison, CVAC is a better buy in the long-term than MRNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVAC’s TA Score shows that 3 TA indicator(s) are bullish while MRNA’s TA Score has 5 bullish TA indicator(s).

  • CVAC’s TA Score: 3 bullish, 4 bearish.
  • MRNA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MRNA is a better buy in the short-term than CVAC.

Price Growth

CVAC (@Biotechnology) experienced а -13.09% price change this week, while MRNA (@Biotechnology) price change was -19.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Reported Earning Dates

CVAC is expected to report earnings on Aug 14, 2025.

MRNA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRNA($9.71B) has a higher market cap than CVAC($581M). CVAC YTD gains are higher at: -24.047 vs. MRNA (-39.610). CVAC has higher annual earnings (EBITDA): 166M vs. MRNA (-3.39B). MRNA has more cash in the bank: 7.03B vs. CVAC (555M). CVAC has less debt than MRNA: CVAC (40.1M) vs MRNA (747M). MRNA has higher revenues than CVAC: MRNA (3.2B) vs CVAC (543M).
CVACMRNACVAC / MRNA
Capitalization581M9.71B6%
EBITDA166M-3.39B-5%
Gain YTD-24.047-39.61061%
P/E Ratio5.05N/A-
Revenue543M3.2B17%
Total Cash555M7.03B8%
Total Debt40.1M747M5%
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
66
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
19

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVACMRNA
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 26 days ago
77%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Ad is loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CCPAX13.28N/A
N/A
FS Chiron Capital Allocation A
FEBIX13.48-0.51
-3.65%
First Eagle Global Income Builder I
ARAHX5.88-0.30
-4.85%
Aristotle Small/Mid Cap Equity A
JVAYX34.50-1.94
-5.32%
JPMorgan Value Advantage R6
JCVVX21.57-1.46
-6.34%
JHancock Classic Value R5

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with BNTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
-8.80%
BNTX - CVAC
45%
Loosely correlated
-4.30%
MRNA - CVAC
43%
Loosely correlated
-2.41%
MDGL - CVAC
42%
Loosely correlated
-3.89%
ARCT - CVAC
42%
Loosely correlated
-3.95%
AXON - CVAC
39%
Loosely correlated
-7.89%
More